Skip to main content
. 2021 Feb 2;11(1):199–210. doi: 10.3233/JPD-202259

Fig. 4.

Fig. 4

Percentage of volume of tissue activated (VTA) overlap with subthalamic nucleus (STN) correlated with percent improvements in MDS-UPDRS III subscores for axial symptom (A), but not with the percent improvement in total camptocormia (TCC) angles (B) or upper camptocormia (UCC) angles (C). Grey areas represent the 95% confidence intervals (CIs).